Discussions à la une
Nouveau
TechNet webinar: Best practices and lessons learnt on Rubella Containing Vaccine Introduction
Join WHO and the Measles & Rubella Partnership for a practical webinar on rubella-containing vaccine (RCV) introduction, featuring real strategies from the countries navigating this process right now.
What you'll learn- How 11 countries are accessing and optimizing Gavi 6.0 funding for RCV intr...
Discussions
The Global Immunization Newsletter posted this article in February 2017. I share it with you in its entirety.
Participants:
Persons from Immunization Programmes, National Sta-tistics Offices or Research Institutes from Gabon, Guin-ea-Bissau, Madagascar, Morocco, and Senegal; all coun-tries plannin...
UPDATE ON MATERNAL NEONATAL TETANUS ELIMINATION AS OF OCTOBER 2010
WHO/CHERG estimates for causes of child mortality show that Maternal and Neonatal Tetanus (MNT) was responsible for 59,000 neonatal deaths in 2008.Though the figure shows a 92% reduction in mortality from the 800,000 deaths estima...
POST 00446E : USE OF VVMs ON ALL VACCINES
15 April 2002
Dr. Jayaprakash of UNICEF/Micronesia
contributes the following comments on on VVMs. His questions are partly
answered and further information will be sought about study plans and if
other countries than Vietnam are to be involved.
...
- Page :
- 1
Il n'existe aucune discussion disponible ici